Oil Prices Hold Decline as USIran Talks Progress Toward Strait of Hormuz Reopening Inde Navarrette Discusses Nikkis Future Following Obsession Finale Analyst Report Highlights Pinterests Growth Potential Amid Digital Advertising Recovery Indian Equity Markets Edge Higher as Financial Stocks Lead Indecisive RangeBound Movement Persists Swiss Franc and Japanese Yen Strengthen as DeepSeek AI News Spurs SafeHaven Demand Lululemon Athletica LULU Set to Report Quarterly Earnings What Investors May Anticipate Jack In The Box Inc JACK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Focus Teekay Q1 2026 Earnings EPS of 055 Reported Amidst Quiet Market Reaction LLYVA Q4 2025 Earnings EPS Slightly Misses Estimates Amid Resilient Live Entertainment Demand Fluence Energy Q1 2026 Earnings NarrowerThanExpected Loss Stock Declines Uber Q1 2026 Earnings Significant EPS Miss Amid Operational Adjustments EXTR Q1 2026 Earnings EPS Surpasses Estimates Shares Rally Over 7 Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity Helmerich Payne HP Posts Modest Gain Key Levels in Focus NextEra Energy NEE Edges Lower Amid Market Uncertainty LuxExperience LUXE Slides 14 as Selling Pressure Builds Near Support Range Capital Acquisition Corp II RNGT Holds Near 10 Mark Amid Minimal Trading Activity MENA Leaders Advocate for Housing Policies Beyond Construction at Baku Forum Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain Paramount Gold Nevada PZG Slides 148Testing Support Near 126 as Gold Miners Struggle FORR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Leslies Inc LESL Q1 2026 Earnings LargerThanExpected Loss Amid Seasonal Weakness Sonos Q1 2026 Earnings EPS Beats Expectations Despite Narrower Loss Shares Rally 5 National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Sees Slight Decline CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline enGene Holdings Q1 2026 Earnings EPS Beat and Positive Market Response Amid PreRevenue Progress Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines